Polares Medical raises USD 50 M

Polares Medical is developing MRace, a transcatheter system for replacing the posterior leaflet of the mitral valve. The Lausanne company has closed a USD 50 million Series C to fund clinical studies in the United States, Europe and Australia.

Announced on
Round
Series C and later
Amount
USD 50 M
Location
Lausanne, canton of Vaud
Sector
Health & medtech

Investors

  • DC Global Ventures
  • Lumination Partners

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic